Prognostic impact of CD109 expression in myxofibrosarcoma期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Prognostic impact of CD109 expression in myxofibrosarcoma

Authors:	Makoto Emori MD Tomohide Tsukahara MD Kenji Murata MD Shintaro Sugita MD Tomoko Sonoda PhD Mitsunori Kaya MD Tamotsu Soma MD Mikito Sasaki MD Satoshi Nagoya MD Tadashi Hasegawa MD Takuro Wada MD Noriyuki Sato MD Toshihiko Yamashita MD

Institution:	1. Department of Orthopedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan;2. Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan;3. Department of Diagnostic Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan;4. Department of Public Health, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan;5. Department of Orthopedic Surgery, Hokkaido Cancer Center, Sapporo, Hokkaido, Japan;6. Department of Orthopedic Surgery, Saiseikai Otaru Hospital, Otaru, Hokkaido, Japan

Abstract:

Keywords:	myxofibrosarcoma CD109 prognostic marker